Congratulations and best wishes to Stuart Schreiber vasanthi viswanathan and the entire Kojin Tx team

A critical conversation that must be had - now is not the time for parsing words. Very proud that Jnana Therapeutics CEO Joanne Kotz was an important contributor to the group

Incredibly exciting time at Jnana - many more breakthroughs to come!

Wonderful Podcast interview with David Liu and Stuart Schreiber on the evolution of chemical biology and much more. Such great mutual respect between 2 superb scientists. cen.acs.org/biological-che… via C&EN (Chemical & Engineering News)

What an awesome team!!

Looking forward to Joanne Kotz ‘s JPM presentation covering the great progress made by the Jnana Therapeutics team!

Welcome John! Fantastic to have you on the Jnana Therapeutics leadership team

Virtually every person on the Jnana Therapeutics team had an important impact on this program and Development Candidate. I’m in awe of them and humbled to be part of the group.

An incredible group of colleagues at Jnana Therapeutics! Very proud of the culture created by CEO Joanne Kotz where diversity is so highly valued.

What a privilege to work with this amazing group 👇

Outstanding work by the Jnana Therapeutics team! Very excited by the potential of JNT-517 for PKU patients. #PKU

Congratulations to the Jnana Therapeutics team for their outstanding work leading to the FIH with JNT-517. We’re thrilled to have Bain Capital join Jnana’s Board and are looking forward to working with them to continue to advance Jnana.

On #RareDiseaseDay, we’re spotlighting PKU, a rare genetic metabolic disease in which high levels of phenylalanine accumulate in the blood, which can result in neurological impairment & neuropsychological complications. Read about our clinical candidate: bit.ly/3xU87EP

What no one has yet recognized about Biosecurity is that Americans won't care about who invents or doesn't invent new medicines if they don't think they will be able to afford them anyways. rapport.bio/all-stories/us… We need pro-AFFORDABLE innovation policy, not just

It's just not right... why does insurance charge people out-of-pocket for a medicine no one would take if they didn't have to? We need to cap these costs for patients and #fixinsurance. Please share and help, Mariah Carey , Jessica Alba, Marshall Mathers, P!nk, Jerome Bettis!

If you have Type 1 diabetes, insulin keeps you alive. Why do health plans make you “prove” you need it by charging a copay on top of premiums? No Patient Left Behind is working to #FixInsurance & cap high out-of-pocket costs for prescribed medicines. #T1D #diabetes

You should never have to fight cancer AND your insurance company. Half of cancer patients abandon treatment when out-of-pocket costs exceed $2,000. Prescribed medicines, “covered” by an insurer, should be affordable with low or no out-of-pocket cost. Let’s #FixInsurance

Finally! It is happening! After 6 years of hard work by formidable teams in 13 institutions RESOLUTE - Research Empowerment on Solute Carriers, we have ordered and validated the results and are able to share the FOUR (4) papers aimed at assigning functional properties to each human SLC #membranetransporter

45 MILLION Americans suffer from autoimmune diseases—and instead of helping, some health plans make it WORSE. 💥 People pay their premiums, then get slapped with sky-high out-of-pocket costs for their prescription meds. 😡 This is unacceptable. If you or someone you know is

Autoimmune diseases afflict 45 million Americans—and it requires a collective community effort to change that. No Patient Left Behind's Community Quest video shows how investors, innovators, regulators, patients, insurers—and you—make new treatments possible, accessible, and affordable.